Veeva Systems announced Veeva Falcon Safety, an agentic safety operations product designed to streamline adverse-event intake, case processing, and follow-up for biopharma companies of all sizes. The product is intended to reduce costs, accelerate workflows, and maintain compliance. It will work with Veeva Safety and provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance. Falcon Safety is part of Veeva AI, the company’s industry-specific AI offering for life sciences, and is planned for early adopter availability in November 2026. Veeva said it serves more than 1,500 customers and disclosed that the release contains forward-looking statements subject to risks outlined in its Form 10-Q for the fiscal year ended July 31, 2026, and subsequent SEC filings.